Published in Am J Public Health on January 01, 2001
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med (2001) 2.12
Prevention and treatment of hepatitis C in injection drug users. Hepatology (2002) 1.88
Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat (2006) 1.81
Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis (2005) 1.80
Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol (2007) 1.70
Injection drug users: the overlooked core of the hepatitis C epidemic. Clin Infect Dis (2006) 1.61
Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur J Epidemiol (2007) 1.52
The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol (2008) 1.49
Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med (2004) 1.41
Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis. J Urban Health (2007) 1.41
Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000. Hepatology (2007) 1.40
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S. Salud Publica Mex (2007) 1.38
Dosage patterns in methadone treatment: results from a national survey, 1988-2005. Health Serv Res (2008) 1.37
Hepatitis C virus (HCV)-specific immune responses of long-term injection drug users frequently exposed to HCV. J Infect Dis (2008) 1.30
Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs. Public Health Rep (2007) 1.29
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. J Urban Health (2007) 1.21
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat (2008) 1.21
Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users. Clin Infect Dis (2004) 1.10
Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics (2009) 1.07
Hepatitis C among drug users: déjà vu all over again? Am J Public Health (2001) 1.04
Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. J Urban Health (2007) 1.03
States and substance abuse treatment programs: funding and guidelines for infection-related services. Am J Public Health (2008) 1.01
Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression. BMC Infect Dis (2007) 1.00
Hepatitis C management by addiction medicine physicians: results from a national survey. J Subst Abuse Treat (2007) 0.95
Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend (2012) 0.92
A qualitative study among injection drug using women in Rhode Island: attitudes toward testing, treatment, and vaccination for hepatitis and HIV. AIDS Patient Care STDS (2008) 0.89
Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California. BMC Infect Dis (2011) 0.88
Chronic pain and hepatitis C virus infection in opioid dependent injection drug users. J Addict Dis (2011) 0.88
Hepatitis C virus infection is associated with painful symptoms in HIV-infected adults. AIDS Care (2012) 0.85
Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend (2010) 0.83
Managing Hepatitis C in Users of Illicit Drugs. Curr Hepat Rep (2007) 0.82
Molecular and contextual markers of hepatitis C virus and drug abuse. Mol Diagn Ther (2009) 0.80
The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users. Dig Dis Sci (2007) 0.78
DETERMINANTS OF CUTANEOUS INJECTION-RELATED INFECTIONS AMONG INJECTION DRUG USERS AT AN EMERGENCY DEPARTMENT. Open Infect Dis J (2012) 0.77
Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. J Subst Abuse Treat (2012) 0.77
High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance. BMC Infect Dis (2015) 0.77
Impact of hepatitis C status on 20-year mortality of patients with substance use disorders. Addict Sci Clin Pract (2015) 0.75
Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut. Drug Alcohol Rev (2016) 0.75
Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California. Addict Sci Clin Pract (2017) 0.75
No Clinically Relevant Drug-Drug Interactions Between Methadone or Buprenorphine/Naloxone and Anti-Viral Combination Glecaprevir and Pibrentasvir. Antimicrob Agents Chemother (2017) 0.75
Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City. Harm Reduct J (2017) 0.75
Attributable risk percent in case-control studies. Br J Prev Soc Med (1971) 5.21
Epidemiology of hepatitis C. Hepatology (1997) 4.90
Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol (1999) 4.48
Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) (1995) 3.85
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 3.68
Response and follow-up bias in cohort studies. Am J Epidemiol (1977) 3.30
Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust (1993) 3.28
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health (1995) 3.24
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. BMJ (1998) 2.64
A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol (1993) 2.61
Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis (1990) 2.06
High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med (1991) 2.02
Seroepidemiology of viral infections among intravenous drug users in northern California. West J Med (1992) 2.01
Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med (1996) 1.93
Epidemiology of hepatitis B virus infections among injecting drug users: seroprevalence, risk factors, and viral interactions. Epidemiol Rev (1994) 1.87
Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS (1993) 1.72
Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence. Scand J Infect Dis (1996) 1.67
Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS (1992) 1.55
Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS (1996) 1.27
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.24
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
The first and second decades of AIDS among injecting drug users. Br J Addict (1992) 1.15
Bleach use and HIV seroconversion among New York City injection drug users. J Acquir Immune Defic Syndr (1994) 1.15
Field effectiveness of needle disinfection among injecting drug users. J Acquir Immune Defic Syndr (1994) 1.10
Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA (1997) 10.23
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation. N Engl J Med (1993) 5.00
Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998-1999. Am J Public Health (2001) 3.43
High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis (2000) 2.71
Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol (1997) 2.36
The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (2000) 2.20
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med (2001) 2.12
Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction (1999) 1.94
Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. Clin Infect Dis (2001) 1.88
Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology (1994) 1.88
Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J Acquir Immune Defic Syndr (2000) 1.87
Sex trading and psychological distress among women recruited from the streets of Harlem. Am J Public Health (1997) 1.81
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients. J Clin Endocrinol Metab (1997) 1.71
Frequency and thoroughness of STD/HIV risk assessment by physicians in a high-risk metropolitan area. Am J Public Health (1991) 1.71
Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology (1994) 1.68
Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.65
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol (2000) 1.62
Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis (1996) 1.56
Angiotensin convertase activities in human alveolar macrophages: effects of cigarette smoking and sarcoidosis. Science (1979) 1.52
Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet (1993) 1.50
Skin innervation at different depths correlates with small fibre function but not with pain in neuropathic pain patients. Eur J Pain (2012) 1.45
Suicidal behavior and sexual/physical abuse among street youth. Child Abuse Negl (1998) 1.42
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology (1999) 1.42
The high-risk sexual practices of crack-smoking sex workers recruited from the streets of three American cities. The Multicenter Crack Cocaine and HIV Infection Study Team. Sex Transm Dis (1998) 1.42
CnNK-2, an NK-2 homeobox gene, has a role in patterning the basal end of the axis in hydra. Dev Biol (1996) 1.32
Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend (1996) 1.31
Relationship between drug use and sexual behaviors and the occurrence of sexually transmitted diseases among high-risk male youth. Sex Transm Dis (1994) 1.24
The inverse relationship between chronic HBV and HCV infections among injection drug users is associated with decades of age and drug use. J Viral Hepat (2008) 1.22
Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr (2001) 1.22
Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention. West J Med (2000) 1.21
Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.21
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat (2008) 1.21
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
HIV seroprevalence in injection drug users. JAMA (1995) 1.19
A serial study of new MS lesions and the white matter from which they arise. Neurology (1998) 1.17
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med (1998) 1.17
Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement. Drug Alcohol Depend (2005) 1.16
Living arrangements affect dietary quality for U.S. adults aged 50 years and older: NHANES III 1988-1994. J Nutr (2000) 1.15
Living arrangements, changes in living arrangements, and survival among community dwelling older adults. Am J Public Health (1997) 1.13
Crack cocaine use and sexual activity in Miami, Florida. J Psychoactive Drugs (1993) 1.12
Expression of Cnox-2, a HOM/HOX gene, is suppressed during head formation in hydra. Dev Biol (1993) 1.10
Smokeless tobacco cessation intervention for college athletes: results after 1 year. Am J Public Health (1999) 1.10
HIV infection among female injection-drug users recruited in community settings. Sex Transm Dis (1995) 1.05
Sex trading and psychological distress in a street-based sample of low-income urban men. J Psychoactive Drugs (2001) 1.03
Hepatitis C patients' self-reported adherence to treatment with pegylated interferon and ribavirin. Aliment Pharmacol Ther (2008) 1.02
Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Br J Ophthalmol (1996) 1.02
A school immunization law is successful in Texas. Public Health Rep (1975) 1.02
Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) (1998) 1.01
Microstructure of primary tooth dentin. Pediatr Dent (2000) 1.00
Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 0.96
Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites. Am J Gastroenterol (2000) 0.95
Use of health care services by women who use crack cocaine. Women Health (1999) 0.95
Ways of coping with cystic fibrosis: implications for treatment adherence. Disabil Rehabil (2001) 0.93
HyAlx, an aristaless-related gene, is involved in tentacle formation in hydra. Development (2000) 0.93
Storage effects on dentin permeability and shear bond strengths. Dent Mater (1993) 0.92
Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3,070 cases in New York City in 1987. J Acquir Immune Defic Syndr (1993) 0.92
A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumonia. Clin Infect Dis (1997) 0.91
Evaluation of infection control measures in preventing the nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in a New York City hospital. Infect Control Hosp Epidemiol (1995) 0.91
Urban rape survivors: characteristics and prevalence of human immunodeficiency virus and other sexually transmitted infections. Multicenter Crack Cocaine and HIV Infection Study Team. Obstet Gynecol (1995) 0.90
Spectroscopic changes in human dentine exposed to various storage solutions--short term. J Dent (1996) 0.89
Genetic variation in CLDN1 and susceptibility to hepatitis C virus infection. J Viral Hepat (2009) 0.88
Influence of gender on cardiovascular mortality in acute myocardial infarction patients with high indication for coronary angiography. Circulation (1997) 0.88
Interferon-alpha plus zidovudine in HIV infection. Lancet (1989) 0.88
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disability. Arch Neurol (1999) 0.87
Double-layer mediated electromechanical response of amyloid fibrils in liquid environment. ACS Nano (2010) 0.86
Effects of Nd: and Ho:yttrium-aluminium-garnet lasers on human dentine fluid flow and dental pulp-chamber temperature in vitro. Arch Oral Biol (1997) 0.86
Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'. Eye (Lond) (2004) 0.86
Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS. J Neuroimmunol (2001) 0.84
CnOtx, a member of the Otx gene family, has a role in cell movement in hydra. Dev Biol (1999) 0.84
Contemporary psychosocial issues in cystic fibrosis: treatment adherence and quality of life. Disabil Rehabil (1998) 0.83
Cross cultural differences in health related quality of life in adolescents with cystic fibrosis. Disabil Rehabil (2001) 0.83
A spit tobacco cessation intervention for college athletes: three-month results. Adv Dent Res (1997) 0.82
Perceived body image and eating behavior in young adults with cystic fibrosis and their healthy peers. J Behav Med (2000) 0.81
IFN-beta1a may increase serum levels of TIMP-1 in patients with relapsing-remitting multiple sclerosis. J Interferon Cytokine Res (2001) 0.80
Variations in medical care for HIV-related Pneumocystis carinii pneumonia: a comparison of process and outcome at two hospitals. Chest (1997) 0.79
Harm reduction and needle exchange programmes. Lancet (1998) 0.77
Severe hyperbilirubinemia after creation of transjugular intrahepatic portosystemic shunts: natural history and predictors of outcome. Ann Intern Med (1998) 0.76
Serogroups of the beer spoilage bacterium Megasphaera cerevisiae correlate with the molecular weight of the major EDTA-extractable surface protein. Can J Microbiol (2000) 0.76
In a managed care setting, are there sex differences in the use of coronary angiography after acute myocardial infarction? Am Heart J (1998) 0.76
Epitope mapping of monoclonal antibodies specific for the directly cross-linked mesodiaminopimelic acid peptidoglycan found in the anaerobic beer spoilage bacterium Pectinatus cerevisiiphilus. Can J Microbiol (1999) 0.76
Cost-effectiveness of hepatitis B virus immunization. JAMA (1996) 0.75
Health care use by human immunodeficiency virus-infected students at a California student health service. West J Med (1992) 0.75
Clusters of multidrug-resistant tuberculosis. Ann Intern Med (1993) 0.75
A parametric approach to population bioequivalence. Stat Med (1997) 0.75
Letter: Enteric-coated potassium supplements. JAMA (1974) 0.75
Change of HAART. Highly active antiretroviral therapy. Lancet (1999) 0.75